These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2765720)

  • 1. Development and application of a system for monitoring drug abuse: the Malaysian experience.
    Navaratnam V; Foong K
    Bull Narc; 1989; 41(1-2):53-65. PubMed ID: 2765720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an information reporting system on illicit drug use in Mexico.
    Ortiz A; Romano M; Soriano A
    Bull Narc; 1989; 41(1-2):41-52. PubMed ID: 2788472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological assessment of drug dependence in Malaysia--a trend analysis.
    Navaratnam V; Foong K
    Med J Malaysia; 1989 Jun; 44(2):92-103. PubMed ID: 2626130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current situation relating to drug abuse assessment in European countries.
    Hartnoll RL
    Bull Narc; 1986; 38(1-2):65-80. PubMed ID: 3490892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures to assess drug abuse and the health, social and economic consequences of such abuse: summary of information from 21 countries. United Nations Secretariat.
    Bull Narc; 1983; 35(3):19-32. PubMed ID: 6608385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems of drug abuse and preventive measures in Poland.
    Tobolska-Rydz H
    Bull Narc; 1986; 38(1-2):99-104. PubMed ID: 3779183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on cancer diagnosis in Malaysia: current status.
    Looi LM; Zubaidah Z; Cheah PL; Cheong SK; Gudum HR; Iekhsan O; Ikram SI; Jamal R; Mak JW; Othman NH; Puteri JN; Rosline H; Sabariah AR; Seow HF; Sharifah NA;
    Malays J Pathol; 2004 Jun; 26(1):13-27. PubMed ID: 16190103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.
    Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programme development of drug abuse control in Baluchistan, Pakistan.
    Zaidi SM; Ashraf SM; Afridi AA
    Bull Narc; 1982; 34(1):23-6. PubMed ID: 6923751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outline of the World Health Organization's programme on epidemiological studies of non-medical drug use and drug dependence.
    Chruściel TL
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):114-20. PubMed ID: 1172488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions to problems of drug abuse in Zambia.
    Haworth A
    Bull Narc; 1983; 35(1):1-9. PubMed ID: 6555052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse in the Republic of Croatia and National Program for Drug Control.
    Sakoman S
    Croat Med J; 2000 Sep; 41(3):270-86. PubMed ID: 10962046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New challenges and opportunities in managing substance abuse in Malaysia.
    Mazlan M; Schottenfeld RS; Chawarski MC
    Drug Alcohol Rev; 2006 Sep; 25(5):473-8. PubMed ID: 16939945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience in the development of information systems at the canton level].
    Beslagić Z; Pasić A
    Med Arh; 1999; 53(3 Suppl 3):31-3. PubMed ID: 10870621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends of drug abuse in Japan.
    Yamamoto J
    Ann N Y Acad Sci; 2004 Oct; 1025():430-8. PubMed ID: 15542746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004.
    Giraudon I; Bello PY
    Subst Use Misuse; 2007; 42(10):1567-78. PubMed ID: 17918027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-based prevention of substance abuse.
    De La Haye W
    West Indian Med J; 2004 Dec; 53(6):420-3. PubMed ID: 15816272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
    Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
    Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sales statistics in the control of drug abuse in Norway.
    Jøldal B; Halvorsen I
    Bull Narc; 1982; 34(2):57-68. PubMed ID: 6129015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.